Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesAlcon Inc.

Alcon Inc.

PortfolioPortfolio WatchlistWatchlist
Company price
None GBX 0.00(0%)
Last update at 2026-10-28T03:28:37.631800Z
Market Cap
3456319.08M
P/E
0.79

Momentum Score

…

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
56.46
Low
86.94
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Alcon Inc. is a global eye-care company supplying surgical equipment and vision-care products, including intraocular lenses, surgical systems, contact lenses and lens-care solutions. Long-term growth may be supported by aging populations increasing cataract procedures, uptake of premium lenses, recurring consumables and product innovation across developed and emerging markets, which may attract investors seeking exposure to procedure-driven healthcare demand.

Major risks include strong competitive and pricing pressure, sensitivity to elective surgery volumes, regulatory or reimbursement changes and execution risk on new products.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
57.76
Dividend Yield
0.49%
Revenue TTM
10401.00M
Revenue Per Share
21.09
Gross Profit TTM
5790.00M
Debt / Equity
0.24
ROE
4.50%
Net Debt
3464.00M
ROCE
4.87%
Diluted EPS TTM
0.91

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax 1256.00M 832.00M 428.09M 381.34M -562.17M
Net income 1018.00M 974.00M 309.74M 343.02M -470.10M
Selling general administrative - - - - 2672.00M
Gross profit 5515.00M 5247.00M 4444.50M 4284.16M 2708.16M
Ebit 1368.00M 1022.00M 758.16M 727.10M -459.48M
Ebitda 2501.00M 2150.00M 1728.06M 1763.48M 905.67M
Depreciation and amortization 1133.00M 1128.00M 969.89M 1036.37M 1365.15M
Operating income 1413.00M 1039.00M 758.16M 727.10M -459.48M
Other operating expenses 8498.00M 8416.00M 7522.46M 7075.80M 6507.03M
Interest expense 149.00M - - 0.00M 0.00M
Tax provision - - - - -104.00M
Interest income - - - - 140.00M
Income tax expense 238.00M -142.00M 118.35M 38.32M 92.07M
Total revenue 9911.00M 9455.00M 8059.65M 7563.88M 6049.32M
Total operating expenses 4102.00M 4208.00M 3907.32M 3796.08M 3165.87M
Cost of revenue 4396.00M 4208.00M 3615.15M 3279.72M 3341.16M
Total other income expense net -157.00M -207.00M -330.08M -345.76M -102.70M
Net income applicable to common shares - - 335.00M 376.00M -531.00M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 30347.00M 29614.00M 27006.35M 25543.49M 24434.56M
Intangible assets 8587.00M 9060.00M 8958.35M 7996.31M 7410.04M
Other current assets 347.00M 338.00M 304.19M 288.29M 281.53M
Total liab 8794.00M 8990.00M 8813.19M 7976.24M 7771.25M
Total stockholder equity 21553.00M 20624.00M 18193.16M 17567.25M 16663.30M
Deferred long term liab - - - 557.00M 727.00M
Other current liab 1332.00M 1453.00M 1776.14M 1431.40M 1223.50M
Common stock 20.00M 20.00M 18.49M 18.25M 17.71M
Retained earnings - - - - 18899.00M
Other liab - - 1850.00M 1966.00M 2256.00M
Good will 8946.00M 8926.00M 8293.57M 8124.03M 7883.69M
Other assets - - 770.18M 737.14M 1341.24M
Cash 1676.00M 1094.00M 906.10M 1436.87M 1378.43M
Total current liabilities 2278.00M 2480.00M 2572.21M 2255.21M 1999.03M
Net debt 3464.00M 3980.00M -906.10M -1436.87M -1378.43M
Short term debt 173.00M 216.00M - - 12.00M
Short long term debt total 5140.00M 5145.00M - - 4264.00M
Other stockholder equity - - 18174.67M 17549.00M 16645.60M
Property plant equipment - - 4416.00M 4083.00M 3783.00M
Total current assets 6309.00M 5647.00M 4801.40M 4913.65M 4415.04M
Net tangible assets - - 1018.00M 2143.00M 1547.00M
Short term investments 165.00M 7.00M - 2.74M 10.62M
Net receivables 1853.00M 1886.00M 1641.15M 1453.29M 1299.64M
Long term debt - - - - 3949.00M
Inventory 2268.00M 2322.00M 1949.96M 1732.46M 1455.45M
Accounts payable 773.00M 811.00M 796.07M 823.81M 775.53M
Accumulated other comprehensive income 21533.00M 20604.00M - - -
Non currrent assets other 1384.00M 1110.00M -21434.77M -19892.70M -18678.27M
Non current assets total 24038.00M 23967.00M 21434.77M 19892.70M 18678.27M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments - - 31.00M -18.00M -11.00M
Change to liabilities - - -48.00M 60.00M -21.00M
Total cashflows from investing activities -1167.00M -1094.00M -1865.00M -1198.00M -572.00M
Net borrowings - - 208.00M -63.00M 536.00M
Total cash from financing activities -322.00M -211.00M -7.40M -112.21M 412.55M
Change to operating activities - - -192.00M 88.00M -23.00M
Net income 1018.00M 974.00M 309.74M 343.02M -470.10M
Change in cash 582.00M 114.00M -530.77M 58.44M 583.04M
Begin period cash flow 1094.00M 980.00M 1436.87M 1378.43M 795.39M
End period cash flow 1676.00M 1094.00M 906.10M 1436.87M 1378.43M
Total cash from operating activities 2077.00M 1388.00M 1125.23M 1227.04M 728.61M
Depreciation 1216.00M 1219.00M 1040.16M 1110.27M 1435.09M
Other cashflows from investing activities -633.00M -434.00M - - -5.00M
Dividends paid 130.00M 116.00M 92.46M 49.26M 54.00M
Change to inventory -47.00M -271.00M -200.64M -297.41M -140.76M
Change to account receivables -55.00M -110.00M -151.63M -180.64M 38.07M
Sale purchase of stock -47.00M -49.00M -46.23M -20.07M -14.16M
Other cashflows from financing activities -8.00M 38.00M 1282.41M 22.81M 487.81M
Change to netincome - - 380.00M 128.00M -101.00M
Capital expenditures 473.00M 660.00M 588.04M 638.61M 424.06M
Change in working capital -261.00M -613.00M -352.27M -478.05M -102.70M
Stock based compensation 150.00M 159.00M 140.54M 137.76M 100.04M
Other non cash items -46.00M -351.00M -12.94M 114.04M -233.72M
Free cash flow 1604.00M 728.00M 537.19M 588.43M 304.55M

Peer Comparison*

Sector: Industry:

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
0R15
SoftBank Group Corp.		 248.00
5.84%		 4494.00 - - - -
0R1E
Nintendo Co. Ltd.		 -115.00
1.34%		 8476.00 - - - -
0LC3
Synchrony Financial		 2.34
3.20%		 75.60 0.09 - 4.97 -
0HQP
CBRE Group Inc. Cl A		 0.15
0.12%		 122.47 0.25 - 1.18 -

Profile*

Alcon Inc.

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Chemin de Blandonnet 8, Geneva, Switzerland, 1214

41 589 112 110

https://www.alcon.com

25942

Name Title Year Born
Mr. F. Michael Ball Exec. Chairman 1955
Mr. David J. Endicott CEO & Director 1965
Mr. Arthur B. Cummings M.D. Exec. Director 1962
Mr. Timothy C. Stonesifer Chief Financial Officer 1967
Margaret Buckley Chief Accounting Officer NA
Dr. Franck Leveiller Sr. VP, Head of Global R&D and Chief Scientific Officer NA
Ms. Sue-Jean Lin Sr. VP & Chief Information and Transformation Officer 1969
Mr. Royce R. Bedward Sr. VP, Gen. Counsel & Corp. Sec. 1966
Mr. Laurent Attias Head of Corp. Devel., Strategy, BD&L and M&A 1968
Ms. Kimberly Martin Sr. VP & Chief HR Officer 1975

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…